The results showed that age, preoperative serum CEA, CA19-9, and CA125, differentiation status, T stage, N stage, KRAS mutation, and postoperative chemotherapy were independent prognostic factors for the prognosis of rectal cancer (Table 3). The gene discussed is KRAS; the disease is rectal cancer.